[HTML][HTML] Pharmacological and clinical application of heparin progress: An essential drug for modern medicine
M Qiu, S Huang, C Luo, Z Wu, B Liang, H Huang… - Biomedicine & …, 2021 - Elsevier
Heparin is the earliest and most widely used anticoagulant and antithrombotic drug that is
still used in a variety of clinical indications. Since it was discovered in 1916, after more than …
still used in a variety of clinical indications. Since it was discovered in 1916, after more than …
Bivalirudin versus Heparin on net adverse clinical events, major adverse Cardiac and cerebral events, and bleeding in Elderly Chinese patients treated with …
Q Li, H Li, Z Liu, L Duan - The Tohoku Journal of Experimental …, 2024 - jstage.jst.go.jp
Bivalirudin as an anticoagulant reduces bleeding after percutaneous coronary intervention
(PCI), while its impact in elderly Chinese patients treated with PCI needs more evidence …
(PCI), while its impact in elderly Chinese patients treated with PCI needs more evidence …
Safety of bivalirudin combined with ticagrelor in the emergency PCI in patients with acute ST-segment elevation myocardial infarction
ZD Wang, YX Chen, M Liu, P Li… - Clinical and Applied …, 2022 - journals.sagepub.com
Objective The present study aimed to investigate the application safety of bivalirudin
combined with ticagrelor in the emergency percutaneous coronary intervention (PCI) in …
combined with ticagrelor in the emergency percutaneous coronary intervention (PCI) in …
急性心肌梗死患者PCI 延时与无延时应用比伐芦定的对照研究
李雪冬， 胡业梅， 王真， 吴纲， 李君， 武永元， 商卓 - 中华全科医学, 2022 - zhqkyx.net
目的评价急性心肌梗死(AMI) 患者接受经皮冠状动脉介入治疗(PCI) 时无延时比伐芦定联合仅冠
脉内替罗非班方案的疗效和安全性. 方法选取2020 年4 月—2021 年3 月蚌埠市第二人民医院心 …
脉内替罗非班方案的疗效和安全性. 方法选取2020 年4 月—2021 年3 月蚌埠市第二人民医院心 …
[PDF][PDF] 南京市栖霞区3~ 5 岁儿童乳牙患龋现状调查及其影响因素分析
陈嵩， 计艳， 项洁， 郑丽纯， 谢丽 - 现代生物医学进展, 2022 - biomed.cnjournals.com
摘要目的: 调查南京市栖霞区3~ 5 岁儿童乳牙患龋现状, 并分析患龋的影响因素. 方法: 于2020
年1 月到2020 年12 月, 采用整群随机抽样法, 抽取南京市栖霞区8 所幼儿园中符合3~ 5 …
年1 月到2020 年12 月, 采用整群随机抽样法, 抽取南京市栖霞区8 所幼儿园中符合3~ 5 …
[HTML][HTML] Effect of bivalirudin on myocardial microcirculation and adverse events after interventional therapy in older patients with acute coronary syndrome
YK Du, LJ Cui, HB Gao - World Journal of Clinical Cases, 2024 - ncbi.nlm.nih.gov
BACKGROUND Bivalirudin, a direct thrombin inhibitor, is used in anticoagulation therapies
as a substitute for heparin, especially during cardiovascular procedures such as …
as a substitute for heparin, especially during cardiovascular procedures such as …
[PDF][PDF] 比伐卢定联合替罗非班在高血栓负荷拟行PPCI 治疗的急性ST 段抬高型心肌梗死患者中的应用价值
褚杰， 王喜福， 杨婷， 殷少杰， 郭玮 - 现代生物医学进展, 2022 - biomed.cnjournals.com
摘要目的: 探讨替罗非班与比伐卢定联合治疗在高血栓负荷拟行直接经皮冠状动脉介入(PPCI)
的急性ST 段抬高型心肌梗死(STEMI) 患者中的应用价值. 方法: 选取我院于2018 年3 月~ 2020 …
的急性ST 段抬高型心肌梗死(STEMI) 患者中的应用价值. 方法: 选取我院于2018 年3 月~ 2020 …
[HTML][HTML] 比伐卢定在冠状动脉分叉病变介入治疗中的疗效观察
项朝君， 毛琦， 田京都， 郑薇， 王玉清， 周渝， 赵晓辉 - 2019 - aammt.tmmu.edu.cn
目的观察比伐卢定应用于冠状动脉分叉病变介入治疗中的有效性和安全性. 方法本研究为回顾性
队列研究, 连续纳入2016 年1~ 12 月于本所经冠脉造影明确的329 例冠脉分叉病变介入治疗 …
队列研究, 连续纳入2016 年1~ 12 月于本所经冠脉造影明确的329 例冠脉分叉病变介入治疗 …
Drugs that affect blood coagulation, fibrinolysis and hemostasis
SC Choi, J Wilczynski, D Tompkins… - Side Effects of Drugs …, 2020 - Elsevier
This chapter reviewed 2019 publications that identify side effects of drugs that affect blood
coagulation, fibrinolysis and hemostasis. Publications on warfarin, apixaban, dabigatran …
coagulation, fibrinolysis and hemostasis. Publications on warfarin, apixaban, dabigatran …
[HTML][HTML] Myocardial damage after ST-segment elevation myocardial infarction by use of bivalirudin or heparin: a DANAMI-3 substudy
MM Schoos… - … of EuroPCR in …, 2020 - eurointervention.pcronline.com
Methods This is a non-randomised post hoc analysis of the DANAMI-3 trial programme in
patients with available CMR 2. Patients (n= 730) were evaluated with an acute CMR after …
patients with available CMR 2. Patients (n= 730) were evaluated with an acute CMR after …